Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: Data from a large US-population database

Journal of Clinical Oncology

Volumn 23, Issue 28, 2005, Pages 7114-7124

  Smith, David D ^a   Schwarz, Rebecca R ^a   Schwarz, Roderich E ^a  

^a RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DATA BASE; FEMALE; GASTRECTOMY; HUMAN; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; STOMACH ADENOCARCINOMA; UNITED STATES; ADOLESCENT; CANCER REGISTRY; FACTUAL DATABASE; FOLLOW UP; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; STATISTICS; STOMACH TUMOR; SURVIVAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; SEER PROGRAM; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 27244439980     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2005.14.621     Document Type: Article

References (37)

1. Jemal A, Tiwari RC, Murray T, et al: Cancer statistics, 2004. CA Cancer J Clin 54:8-29, 2004
2. Roder JD, Bottcher K, Siewert JR, et al: Prognostic factors in gastric carcinoma: Results of the German Gastric Carcinoma Study 1992. Cancer 72:2089-2097, 1993
3. Kodera Y, Yamamura Y, Shimizu Y, et al: The number of metastatic lymph nodes: A promising prognostic determinant for gastric carcinoma in the latest edition of the TNM classification. J Am Coll Surg 187:597-603, 1998
4. Roukos DH, Lorenz M, Karakostas K, et al: Pathological serosa and node-based classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients: A prospective with quality control 10-year follow-up study. Br J Cancer 84:1602-1609, 2001
5. Schwarz RE, Zagala-Nevarez K: Recurrence patterns after radical gastrectomy for gastric cancer: Prognostic factors and implications for postoperative adjuvant therapy. Ann Surg Oncol 9:394-400, 2002
6. Kodera Y, Schwarz RE, Nakao A: Extended lymph node dissection in gastric carcinoma: Where do we stand after the Dutch and British randomized trials? J Am Coll Surg 195:855-864, 2002
7. Bonenkamp JJ, Hermans J, Sasako M, et al: Extended lymph-node dissection for gastric cancer. Dutch Gastric Cancer Group. N Engl J Med 340:908-914, 1999
8. Cuschieri A, Weeden S, Fielding J, et al: Patient survival after D1 and D2 resections for gastric cancer: Long-term results of the MRC randomized surgical trial. Surgical Cooperative Group. Br J Cancer 79:1522-1530, 1999
9. Siewert JR, Kestlmeier R, Busch R, et al: Benefits of D2 lymph node dissection for patients with gastric cancer and pN0 and pN1 lymph node metastases. Br J Surg 83:1144-1147, 1996
10. Sasako M, McCulloch P, Kinoshita T, et al: New method to evaluate the therapeutic value of lymph node dissection for gastric cancer. Br J Surg 82:346-351, 1995
11. Karpeh MS, Leon L, Klimstra D, et al: Lymph node staging in gastric cancer: Is location more important than number? An analysis of 1,038 patients. Ann Surg 232:362-371, 2000
12. Wanebo HJ, Kennedy BJ, Chmiel J, et al: Cancer of the stomach: A patient care study by the American College of Surgeons. Ann Surg 218:583-592, 1993
13. Hundahl SA, Menck HR, Mansour EG, et al: The National Cancer Data Base report on gastric carcinoma. Cancer 80:2333-2341, 1997
14. Hundahl SA, Phillips JL, Menck HR: The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the "different disease" hypothesis. Cancer 88:921-932, 2000
15. Fleming ID, Cooper JS, Henson DE, et al: American Joint Committee on Cancer Staging Manual (ed 5). Philadelphia, PA, Lippincott-Raven, 1997
16. Roder JD, Bottcher K, Busch R, et al: Classification of regional lymph node metastasis from gastric carcinoma. German Gastric Cancer Study Group. Cancer 82:621-631, 1998
17. Bouvier AM, Haas O, Piard F, et al: How many nodes must be examined to accurately stage gastric carcinomas? Results from a population based study. Cancer 94:2862-2866, 2002
18. Lee HK, Yang HK, Kim WH, et al: Influence of the number of lymph nodes examined on staging of gastric cancer. Br J Surg 88:1408-1412, 2001
19. Siewert JR, Bottcher K, Stein HJ, et al: Relevant prognostic factors in gastric cancer: Ten-year results of the German Gastric Cancer Study. Ann Surg 228:449-461, 1998
20. National Cancer Statistics Branch. Surveillance, Epidemiology and End Results (SEER) Program: Public Use CD-ROM (1973-2000). Bethesda, MD, National Cancer Statistics Branch, 2000
21. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
22. Peto R, Pike MC: Conservatism in the approximation E(0-E)2/E in the log rank test for survival data or tumor incidence data. Biometrics 29:579-584, 1973
23. Cox DR: Regression models and life tables. J R Stat Soc B 34:187-220, 1972
24. Cserni G, Vinh-Hung V, Burzykowski T: Is there a minimum number of lymph nodes that should be histologically assessed for a reliable nodal staging of T3N0M0 colorectal carcinomas? J Surg Oncol 81:63-69, 2002
25. Adachi Y, Suematsu T, Shiraishi N, et al: Perigastric lymph node status as a prognostic indicator in patients with gastric cancer. Br J Surg 85:1281-1284, 1998
26. de Manzoni G, Verlato G, Roviello F, et al: The new TNM classification of lymph node metastasis minimises stage migration problems in gastric cancer patients. Br J Cancer 87:171-174, 2002
27. Borie F, Plaisant N, Millat B, et al: Appropriate gastric resection with lymph node dissection for early gastric cancer. Ann Surg Oncol 11:512-517, 2004
28. Hartgrink HH, Van De Velde CJ, Putter H, et al: Extended lymph node dissection for gastric cancer: Who may benefit? Final results of the randomized Dutch gastric cancer group trial. J Clin Oncol 22:2069-2077, 2004
29. Hannan EL, Radzyner M, Rubin D, et al: The influence of hospital and surgeon volume on in-hospital mortality for colectomy, gastrectomy, and lung lobectomy in patients with cancer. Surgery 131:6-15, 2002
30. Callahan MA, Christos PJ, Gold HT, et al: Influence of surgical subspecialty training on in-hospital mortality for gastrectomy and colectomy patients. Ann Surg 238:629-636; discussion 636-639, 2003
31. Dhar DK, Kubota H, Tachibana M, et al: Body mass index determines the success of lymph node dissection and predicts the outcome of gastric carcinoma patients. Oncology 59:18-23, 2000
32. Hundley JC, Shen P, Shiver SA, et al: Lymphatic mapping for gastric adenocarcinoma. Am Surg 68:931-935, 2002
33. Song X, Wang L, Chen W, et al: Lymphatic mapping and sentinel node biopsy in gastric cancer. Am J Surg 187:270-273, 2004
34. Macdonald JS, Smalley SR, Benedetti J, et al: Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725-730, 2001
35. Hundahl SA, Macdonald JS, Benedetti J, et al: Surgical treatment variation in a prospective, randomized trial of chemoradiotherapy in gastric cancer: The effect of undertreatment. Ann Surg Oncol 9:278-286, 2002
36. Kattan MW, Karpeh MS, Mazumdar M, et al: Postoperative nomogram for disease-specific survival after an RO resection for gastric carcinoma. J Clin Oncol 21:3647-3650, 2003
37. Nitti D, Marchet A, Olivieri M, et al: Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: Analysis of a large European monoinstitutional experience. Ann Surg Oncol 10:1077-1085, 2003